Below is the **final unified plan**, fully integrating the key decisions and technical insights from **answers 5â€“8**, expressed as a clear blueprint you can execute in your clinical trial.

---

# âœ… **Final Plan: Open-Source, Scalable CT-Based Î”FFR Estimation Pipeline**

This plan is specifically optimized for your dataset:

âœ” Hundreds of **partially** segmented arteries
âœ” STL available for both **lumen** and **outer wall**
âœ” Goal = **Î”FFR (pressure drop across lesion)** from geometry
âœ” Use **open, validated reduced-order physics**
âœ” Industrial-grade **uncertainty quantification**
âœ” Minimal HPC required
âœ” Clinically interpretable outputs

---

## ðŸš€ Strategic Summary

| Component               | Choice                                                                         | Rationale                             |
| ----------------------- | ------------------------------------------------------------------------------ | ------------------------------------- |
| Modeling                | **1D reduced-order hemodynamics**                                              | Accurate for Î”P; massively scalable   |
| Solver                  | **Python implementation of Lyras model** (with optional SimVascular 1D solver) | Removes CFD bottleneck                |
| Geometry source         | **STL lumen + STL outer wall**                                                 | Enables counterfactual reconstruction |
| Healthy reference lumen | **Outer-wallâ€“guided taper (Glagov-aware)**                                     | Most biologically plausible           |
| Boundary conditions     | **Murray flow + hyperemia** + Windkessel                                       | Matches clinical FFR physiology       |
| Output                  | Î”P, Î”FFR, **uncertainty interval**, QC flags                                   | Required for regulatory path          |
| Validation              | Invasive FFR subset + 3D CFD subset                                            | Clinical & physical credibility       |

---

## ðŸ”¬ Pipeline (6 Automated Stages)

```
STL_lumen + STL_outer
      â†“
Centerline + A(s)
      â†“
Reference A_ref(s) (outer-wall constrained)
      â†“
Estimate Q_hyperemic + microvascular R_outlet
      â†“
Compute Î”P (Lyras model)
      â†“
Î”FFR = Î”P / P_a (w/ Â±CI)
```

---

## âœ… Stage-by-Stage Decisions

### **1ï¸âƒ£ Centerline & Lumen Profile**

**Tool:** VMTK

Compute:

* Centerline coordinate vs length
* Lumen area A(s)
* Outer wall radius along same centerline

QC metrics:

* Min length, sampling density, self-intersections, bifurcation proximity

---

### **2ï¸âƒ£ Reference (Healthy) Lumen**

Use **outer-wall scaffold** â†’ accounts for remodeling

Steps:
1ï¸âƒ£ Identify healthy segments proximally/distally
2ï¸âƒ£ Fit physiologic **exponential taper**
3ï¸âƒ£ Interpolate A_ref(s) **inside lesion** under constraint:
Â Â Â Â *healthy lumen = outer wall â€“ healthy wall thickness*
4ï¸âƒ£ Monte-Carlo reconstructions for uncertainty

**Key advantage**: You uniquely have both lumen and adventitia â€“ most papers donâ€™t.

---

### **3ï¸âƒ£ Hyperemic Flow + Boundary Conditions**

Physiologic, literature-supported defaults:

| Parameter                | Value                                      | Source                             |
| ------------------------ | ------------------------------------------ | ---------------------------------- |
| Aortic mean pressure P_a | 95â€“100 mmHg                                | invasively validated FFR protocols |
| Hyperemic scaling        | Q_rest Ã— 3.5â€“4                             | Adenosine physiology               |
| Flow split               | Murray exponent Î±â‰ˆ2.7â€“3.0                  | Coronary allometry                 |
| R_out                    | Poiseuille + 75% reduction under hyperemia | Microvascular physiology           |

Partial tree support âœ…
Î”FFR does **not** require distal anatomy.

---

### **4ï¸âƒ£ Reduced-Order Pressure Loss Model**

Use modern literature-validated 1D stenosis formula:

[
\Delta P = K_1 \mu\frac{L}{A_{min}^2} Q

* K_2 \rho\left(\frac{Q}{A_{min}}\right)^2
  ]

- (K_1), (K_2) calibrated on a **small invasive FFR subset**
- Blood viscosity (\mu) â‰ˆ 0.0035â€“0.0040 PaÂ·s
- Density (\rho) â‰ˆ 1050 kg/mÂ³

Compute:
[
\Delta FFR = \frac{\Delta P}{P_a}
]

> **Clinically validated cutoff:**
> Î”P > ~15 mmHg â‰ˆ invasive **FFR < 0.80**

---

### **5ï¸âƒ£ Uncertainty Quantification**

Run ensembles varying:

* Healthy wall thickness (Â±0.2 mm)
* Flow (Â±20%)
* Reference lumen taper exponent (Â±0.005)

Report:
âœ… Median
âœ… 90% confidence interval
âœ… QC flag if CI width >0.05 Î”FFR

---

### **6ï¸âƒ£ Validation Strategy**

Three-layer evidence:

| Layer                  | N   | Purpose                         |
| ---------------------- | --- | ------------------------------- |
| Invasive FFR subset    | â‰¥50 | Calibrate + clinical ROC/AUC    |
| 3D CFD subset          | â‰¥20 | Physics validation              |
| Reproducibility subset | â‰¥40 | Robustness across operator/time |

Goal: AUC > 0.92 for ischemia classification

---

## ðŸ“Š Trial-Level Outputs

For each lesion:

| ID | Î”P (mmHg) | Î”FFR | CI_low | CI_high | MLA | Ref.A | QC |
| -- | --------- | ---- | ------ | ------- | --- | ----- | -- |

For whole cohort:

* Î”FFR distribution
* Performance vs invasive FFR
* Decision-impact simulation (PCI reductions)

---

## âš™ï¸ Tools (all open-source)

| Task                    | Tool                          |
| ----------------------- | ----------------------------- |
| Geometry                | VMTK                          |
| 1D solver               | Python (Lyras implementation) |
| Optional CFD validation | SimVascular / OpenFOAM        |
| Visualization           | PyVista / Matplotlib          |
| Batch execution         | Docker or SLURM (if needed)   |

Full reproducibility âœ…
Clinically defensible âœ…
Regulatory-friendly âœ…

---

# ðŸ§­ What Happens Next

To operationalize:

**Phase 1 (1â€“2 weeks)**
âœ… Implement STL â†’ Î”FFR pipeline (Python)
âœ… Process pilot set of ~20 cases
âœ… Tune Kâ‚, Kâ‚‚ vs invasive FFR (if available)

**Phase 2 (2â€“3 weeks)**
âœ… Full cohort Î”FFR
âœ… Uncertainty quantification
âœ… CFD validation subset

**Phase 3 (1 month)**
âœ… ROC/AUC and decision-impact analysis
âœ… Manuscript + conference abstract (ACC/SCCT/ECR targets)

â€”

## ðŸ”¥ Why This Matters

This pipeline can:

âœ” Reduce unnecessary invasive angiography globally
âœ” Enable noninvasive functional CAD diagnosis in any hospital
âœ” Leverage existing CT datasets â†’ **no extra cost to the system**
âœ” Scale instantly with AI segmentation

> This is likely **publishable in a high-impact journal**
> and potentially **translatable to clinical practice faster** than any new imaging tech.

---

# âœ… Ready when you are

To proceed:

âœ… Send **one anonymized** lumen+outer STL pair
ðŸ“Œ Include vessel name (LAD/LCx/RCA) + approximate location
âœ… I return: Î”P, Î”FFR, CI, QC + visualization

Once validated on your side â†’ full rollout.

---

Would you like me to generate:

A) The complete **Python package** (CLI + docs)?
B) A turnkey **containerized pipeline** (Docker/Singularity)?
C) A study **statistical analysis plan** (regulatory-ready)?
D) All of the above?

Just tell me **A/B/C/D** â€” and whether you want British English in the report (I know you prefer it for scientific proposals ðŸ˜Š).
